Design
Review
Authors
Loading...
INaL inhibition should not yet change practice; leaves open its role as a target pending prospective trials.
Key points are not available for this paper at this time.
Zaza et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: